BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6105055)

  • 1. Gas chromatographic-mass spectrometric studies on the metabolic fate of ethotoin in man.
    Bius DL; Yonekawa WD; Kupferberg HJ; Cantor F; Dudley KH
    Drug Metab Dispos; 1980; 8(4):223-9. PubMed ID: 6105055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometry.
    Lynn RK; Bauer JE; Gordon WP; Smith RG; Griffin D; Thompson RM; Jenkins R; Gerber N
    Drug Metab Dispos; 1979; 7(3):138-44. PubMed ID: 38083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereochemical aspects of the metabolism of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
    Maguire JH; Kraus BL; Butler TC; Dudley KH
    Drug Metab Dispos; 1981; 9(5):393-401. PubMed ID: 6117436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
    Küpfer A; Brilis GM; Watson JT; Harris TM
    Drug Metab Dispos; 1980; 8(1):1-4. PubMed ID: 6102023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass fragmentographic quantitation of ethotoin and some of its metabolites in human urine.
    Naestoft J; Larsen NE
    J Chromatogr; 1977 Mar; 143(2):161-9. PubMed ID: 14171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-ethyl-5-phenylhydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
    Maguire JH; Butler TC; Dudley KH
    Drug Metab Dispos; 1982; 10(6):595-8. PubMed ID: 6130906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary metabolites of benzbromarone in man.
    Maurer H; Wollenberg P
    Arzneimittelforschung; 1990 Apr; 40(4):460-2. PubMed ID: 2357247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biotransformation of zipeprol (Mirsol) in humans. Gas chromatographic/mass spectrometric studies, using ammonia as a selective reactant gas (author's transl)].
    Gielsdorf W; Toffel-Nadolny P
    J Clin Chem Clin Biochem; 1981 Jan; 19(1):25-30. PubMed ID: 7205156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fates of 3-ethyl-5-phenylhydantoin (ethotoin, peganone), 3-methyl-5-phenylhydantoin and 5-phenylhydantoin.
    Dudley KH; Bius DL; Butler TC
    J Pharmacol Exp Ther; 1970 Oct; 175(1):27-37. PubMed ID: 5471450
    [No Abstract]   [Full Text] [Related]  

  • 10. Saturable metabolic pathways for ethotoin in man.
    Naestoft J; Hvidberg EF; Sjö O
    Clin Exp Pharmacol Physiol; 1976; 3(5):453-9. PubMed ID: 10117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buffer catalysis of the racemization reaction of some 5-phenylhydantoins and its relation to the in vivo metabolism of ethotoin.
    Dudley KH; Bius DL
    Drug Metab Dispos; 1976; 4(4):340-8. PubMed ID: 8288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mephenytoin metabolites in the dog.
    Karlaganis G; Küpfer A; Bircher J; Schlunegger UP; Gfeller H; Bigler P
    Drug Metab Dispos; 1980; 8(3):173-7. PubMed ID: 6104582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of mephenytoin and ethotoin.
    Troupin AS; Friel P; Lovely MP; Wilensky AJ
    Ann Neurol; 1979 Nov; 6(5):410-4. PubMed ID: 42344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gas chromatographic assay for tocainide carbamoyl-O-beta-D-glucuronide:quantitation of the base hydrolyzed product, 3-(2',6'-xylyl)-5-methylhydantoin.
    Kwok DW; McErlane KM; Axelson JE
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):395-409. PubMed ID: 2111573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo biotransformation of 17 alpha-methyltestosterone in the horse revisited: identification of 17-hydroxymethyl metabolites in equine urine by capillary gas chromatography/mass spectrometry.
    Dumasia MC
    Rapid Commun Mass Spectrom; 2003; 17(4):320-9. PubMed ID: 12569442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog.
    Moustafa MA; Claesen M; Adline J; Vandervorst D; Poupaert JH
    Drug Metab Dispos; 1983; 11(6):574-80. PubMed ID: 6140142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of di-n-butylphthalate biotransformation in cattle by liquid chromatography/ion trap mass spectrometry/mass spectrometry.
    Coldham NG; Dave M; Sauer MJ
    J Mass Spectrom; 1998 Sep; 33(9):803-10. PubMed ID: 9768498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent kinetics of ethotoin in man.
    Sjö ; Hvidberg EF; Larsen NE; Naestoft J
    Clin Exp Pharmacol Physiol; 1975; 2(3):185-92. PubMed ID: 238776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the metabolism of ditazole in man.
    Maurer H; Kleff I
    Arzneimittelforschung; 1988 Dec; 38(12):1843-5. PubMed ID: 2907728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the metabolism of the amphetamine-derived antispasmodic drug mebeverine: gas chromatography-mass spectrometry studies on rat liver microsomes and on human urine.
    Kraemer T; Bickeboeller-Friedrich J; Maurer HH
    Drug Metab Dispos; 2000 Mar; 28(3):339-47. PubMed ID: 10681380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.